Characteristic | Variable | Total N = 398 | Successful outcome* N = 332 | Unsuccessful outcome* N = 42 |
---|---|---|---|---|
Number (%) unless otherwise indicated | ||||
Gender | Male | 227 (57.0) | 193 (58.1) | 19 (45.2) |
Female | 171 (43.0) | 139 (41.9) | 23 (54.8) | |
Age | 0–4 | 219 (55.0) | 185 (55.7) | 21 (50.0) |
5–15 | 179 (45.0) | 147 (44.3) | 21 (50.0) | |
Mean weight-for-age z-score (SD; n) † | − 2.2 (1.3; n = 300) | − 2.2 (1.3; n = 283) | − 1.9 (1.8; n = 17) | |
Year diagnosed | 2013–2015 | 199 (50.0) | 175 (52.7) | 19 (45.2) |
2016–2018 | 199 (50.0) | 157 (47.3) | 23 (54.8) | |
TB site | Pulmonary‡ | 372 (93.5) | 316 (95.2) | 35 (83.3) |
Extra-pulmonary | 26 (6.5) | 16 (4.8) | 7 (16.7) | |
TB history | New | 357 (89.7) | 322 (97.0) | 28 (66.7) |
Retreatment | 13 (3.3) | 10 (3.0) | 2 (4.7) | |
No data | 28 (7.0) | 0 (0.0) | 12 (28.6) | |
Bacteriologic confirmation | Negative/Not done | 374 (94.0) | 321 (96.7) | 34 (81.0) |
Positive | 24 (6.0) | 11 (3.3) | 8 (19.0) | |
Drug susceptibility | Non-MDR-TB | 394 (99.0) | 330 (99.4) | 40 (95.2) |
MDR-TB | 4 (1.0) | 2 (0.6) | 2 (4.8) | |
Treatment regimen | Category I | 352 (88.4) | 322 (97.0) | 26 (61.9) |
Non-Category I | 15 (3.8) | 10 (3.0) | 4 (9.5) | |
Not started§ | 31 (7.8) | 0 (0.0) | 12 (28.6) | |
HIV status | Negative | 335 (84.2) | 300 (90.4) | 26 (61.9) |
Positive§§ | 39 (9.8) | 29 (8.7) | 5 (11.9) | |
Unknown | 24 (6.0) | 3 (0.9) | 11 (26.2) |